Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

IL17A (Secukinumab Biosimilar) antibody

This anti-IL17A (Secukinumab Biosimilar) antibody is a Human Monoclonal antibody detecting IL17A (Secukinumab Biosimilar) in FACS. Suitable for Human.
Catalog No. ABIN7490998

Quick Overview for IL17A (Secukinumab Biosimilar) antibody (ABIN7490998)

Target

IL17A (Secukinumab Biosimilar)

Reactivity

Human

Host

  • 2
  • 1
Human

Clonality

  • 3
Monoclonal

Conjugate

  • 2
  • 1
This IL17A (Secukinumab Biosimilar) antibody is un-conjugated

Application

  • 2
  • 1
Flow Cytometry (FACS)

Grade

Research Grade
  • Purpose

    Anti-IL17A (Secukinumab biosimilar) mAb

    Characteristics

    AIN457

    Purification

    Purified from cell culture supernatant by affinity chromatography

    Isotype

    IgG1
  • Application Notes

    Flow Cyt  1:100

    Comment

    Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Reconstitute with deionized water

    Buffer

    Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

    Expiry Date

    12 months
  • Target

    IL17A (Secukinumab Biosimilar)

    Target Type

    Biosimilar

    Background

    CTLA-8,CTLA8,IL-17,IL-17A,IL17

    UniProt

    Q16552
You are here:
Chat with us!